Guy P. Nohra, founder of Alta Life Sciences, is now the chair of Bionure's Board

Alta Life Sciences is leading a 4M € round to finance the clinical development of the Bionures’s neuroprotector BN201

Alta Life Sciences is leading a Series A round of 4 million euros to finance the clinical development of Bionure’s lead compound BN201, that has demonstrated its potential to promote neuroprotection and remyelination in the preclinical phase, offering a game-changing solution for neurodegenerative diseases. Bionure, Barcelona based biotech company that develops neuroprotectant agents to treat neurodegenerative diseases primarily focusing on rare ophthalmologic diseases as Acute Optic Neuritis (AON) and Neuromyelitis…

dsc_1736bw

Peptomyc S.L. secures 4.2 million euros in Series A led by Alta Life Sciences

Peptomyc S.L., a Barcelona-based biotech company developing new peptide therapeutics for the treatment of cancer patients, announces the closure of a Series A financing of 4.2 million euros. The investment round was led by Alta Life Sciences Spain I FCR, and includes current investors HealthEquity and business angels, that had already participated in the seed round of 2016. RCD, a leading legal firm in the biotech sector, has advised on…